Related stocks: Cigarettes
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Related stocks: Cigarettes
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. We manufacture and distribute the only combustible tobacco products containing minimally or non-addictive levels of nicotine that are authorized by the US Food and Drug Administration (FDA) for retail purchase.
$4.33
+$0.04 (+0.93%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-65.76% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 27.9% YoY. Margins deteriorated 8.6pp alongside, both lines moving the wrong way.
Negative free cash flow of -$8M. The business is consuming cash, not generating it. Operating margin contracted 8.6pp YoY, cost discipline may be slipping.
0.0x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$16M
▼ -27.9% YoY
Net Income (TTM)
-$4M
▲ +66.7% YoY
Op. Margin
-76.48%
▼ -8.6pp YoY
ROIC
-52.40%
▲ +16.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$8M
▲ +46.3% YoY
Op. Cash Flow (TTM)
-$8M
▲ +46.2% YoY
Net Debt
-$8M
Net Cash Position
Cash & Equiv.
$10M
5Y CAGR: -9.0%
Continue Research
At a P/E of 0.0, 22nd Century Group (XXII)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, 22nd Century Group scores 45/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
22nd Century Group scores 45 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -76.5% operating margin and a -52.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh XXII's valuation and scores 45/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.